openPR Logo
Press release

Global Anti-Viral Drug Therapy Market | Global Anti-Viral Drug Therapy Industry | Global Anti-Viral Drug Therapy Market Research Report: Ken Research

02-18-2021 05:49 PM CET | Health & Medicine

Press release from: Ken Research Pvt Ltd

Global Anti-Viral Drug Therapy Market | Global Anti-Viral Drug

Anti-viral drug therapy market comprises of sales of branded & generic anti-viral drugs and related services by entities that manufacture the branded or generic anti-viral drugs for treating microbial infections. Anti-viral drug therapy industry includes several establishments that manufacture anti-viral drugs, which are used to treat diseases caused by viral infections. Examples of antiviral drugs include cidofovir, amantadine, zanamivir, idoxuridine, famiciclovir, tenofovir, adefovir and ribavirin.

According to study, “Anti-Viral Drug Therapy Global Market Report 2020-30: Covid 19 Implications and Growth” the key companies operating in the global anti-viral drug therapy market are Johnson & Johnson, Gilead Sciences Inc, Merck & Co., Inc, GlaxoSmithKline plc., AbbVie Inc., Aurobindo Pharma, Bristol-Myers-Squibb, Dr. Reddy’s Laboratories Ltd, Boehringer Ingelheim, Hanmi Pharmaceutical, Cipla Inc, Daewoong Pharmaceutical Co. Ltd, KYORIN Holdings, Inc., Fosun Pharma, Jiangsu Hengrui Medicine Co., Ltd., Shanghai Pharmaceuticals, Yangtze River Pharmaceutical Group, Xian-Janssen Pharmaceutical Ltd, Harbin Pharmaceutical Group, Guangzhou Pharmaceutical Company Limited, Xian-Janssen Pharmaceutical Ltd, Harbin Pharmaceutical Group, Shanghai Acebright Pharmaceuticals Group Co., Ltd., Sinopharm Group, Lupin Limited, CSPC Pharmaceutical, China Meheco, Sun Pharma, Zydus Cadila, Divis Laboratories, Intas Pharmaceuticals, Alkem Laboratories, Strides Pharma, Takeda Pharmaceutical Company, Glenmark Pharmaceuticals, Nichi-Iko Pharmaceutical Co., Ltd., Otsuka Pharmaceutical, Chugai Pharmaceutical Co., Daiichi Sankyo, Mitsubishi Tanabe Pharma, Astellas Pharma, Shionogi Co. Ltd., Sumitomo Dainippon Pharma, Teva UK Limited, Eisai, AstraZeneca, Vectura Group, Abbott Laboratories, Roche Holding AG, Novartis AG, Hikma Pharmaceuticals, Pfizer, Pharmasyntez, Sanofi, ChemRar Group, R-Pharm, Pharmstandard, ChemRar Group, Alium, BioCryst Pharmaceuticals Inc., Servier, Novo Nordisk, Emergent BioSolutions, Selva Therapeutics, EMS Pharma, Apotex, Eurofarma, Cristalia, União Quimica, Gulf Pharmaceutical Industries, Libbs, Medical Appliances Corporation (SPIMACO), Saudi Pharmaceutical Industries, BMS, Mylan Laboratories, Ascedis Health. Key companies are increasingly focusing on development & launching of combination drug therapy to treat HIV and other viral infections. Combination therapies involve the formulation of different drugs to treat the different diseases.

Based on drug class, anti-viral drug therapy market is segmented as Protease Inhibitors, DNA (Nucleotide) Polymerase Inhibitors, Neuraminidase Inhibitors, Reverse Transcriptase Inhibitors and others. In addition, based on application, market is segmented as herpes, HIV, influenza, hepatitis and others.

The anti-viral drug therapy market is driven by rise in number of COVID-19 cases, followed by growth in development of drug discovery procedures. However, increase in pricing pressures and patent expiration may impact the market. Moreover, growth in development of advanced technologies is a key opportunity for market.

Based on geography, the North-American region dominates the global anti-viral drug therapy market owing to increase in virus life-threatening diseases like bird flu and strong development pipeline in the region. The Asian-Pacific and European regions are estimated to witness higher growth rate due to rise in healthcare expenditure coupled with growth in research & development (R&D) investments over the forecast period. It is anticipated that future of the global market as a result of increase in incidence rates of viral infections particularly HIV during the forecast period. It is also anticipated that global anti-viral drug therapy market will be reached at US $62.6 billion at a CAGR of 4.6% by 2023.

For More Information, Click on the Link Below:-
https://www.kenresearch.com/healthcare/pharmaceuticals/anti-viral-drug/342096-91.html

Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Ken Research Pvt. Ltd.,
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49 Gurgaon, Haryana - 122001, India

Ken Research is a Global aggregator and publisher of Market intelligence, equity and economy reports. Ken Research provides business intelligence and operational advisory in 300+ verticals underscoring disruptive technologies, emerging business models with precedent analysis and success case studies. Serving over 70% of fortune 500 companies globally, some of top consulting companies and Market leaders seek Ken Research’s intelligence to identify new revenue streams, customer/ vendor paradigm and pain points and due diligence on competition.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Anti-Viral Drug Therapy Market | Global Anti-Viral Drug Therapy Industry | Global Anti-Viral Drug Therapy Market Research Report: Ken Research here

News-ID: 2245059 • Views: 756

More Releases from Ken Research Pvt Ltd

The Australia Crop Protection Industry has grown steadily in the last five years …
The Crop Protection Market in Australia saw a steady growth in the period of 2017-2021, and the market is expected to grow at a robust CAGR in the forecasted period. Australia Crop Protection Market Overview: The Australia Crop Protection Market is currently at the growth stage owing to the technological innovations in the industry, pest pressures, rising use of bio-based crop solutions, rising demand for bio-pesticides and the adoption of herbicide-resistant crops
5 Key Insights on US$ 60 Bn Opportunity in Global Thermoformed Plastics Market: …
Buy Now Driven by the rising consumption of thermoformed plastics material in healthcare and packaging industries, Global Thermoformed Plastics Market is forecasted to Cross US$60 Bn by 2028 says Ken Research Study. Thermoforming is a plastic manufacturing process that applies a vacuum or pressure force to stretch a sheet of heated thermoplastic material over an engineered mold to create a 3-dimensional shape or part. After forming, the shaped part is trimmed and finished
Market Research Subscription Services Encourage You in All Your Requirements: Ke …
During the present trend, the market space is very vivacious in nature. In an endeavor to cope with such continual deviations, market contributors are actively in inevitability of research and consulting studies. The Ken Research as an originator of the market intelligence and wide-fluctuating aggregator, equity and region research reports dispense the business intellect and effective consultative crosswise 300+ vertical underscoring the provocative technologies, emerging business models along the routine
The Emerging Trends of Human Platelet Lysate Industry: Ken Research
The Global Human platelet lysate Market has grown at a significant growth rate in the past few decades. The report insights into the market shares, revenues, and trends. It discusses the data assessments and specifics of the market size and the industry. The report signifies the trending branding assessments of the top grooming companies in the world. The report gives a bright light to the regional and volumetric analysis of

All 5 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications